Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 79–79 | Cite as

Bevacizumab/pemetrexed/unspecified platinum complex

Nausea: case report
Case report
  • 8 Downloads

Reference

  1. Nakasuka T, et al. Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma. Journal of Thoracic Oncology 14: e168-e169, No. 8, Aug 2019. Available from: URL: http://doi.org/10.1016/j.jtho.2019.03.009 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations